Unknown

Dataset Information

0

Ribavirin suppresses bacterial virulence by targeting LysR-type transcriptional regulators.


ABSTRACT: Targeting bacterial virulence mechanisms without compromising bacterial growth is a promising strategy to prevent drug resistance. LysR-type transcriptional regulators (LTTRs) possess structural conservation across bacterial species and regulate virulence in numerous pathogens, making them attractive targets for antimicrobial agents. We targeted AphB, a Vibrio cholerae LTTR, which regulates the expression of genes encoding cholera toxin and toxin-co-regulated pilus for inhibitor designing. Since AphB ligand is unknown, we followed a molecular fragment-based approach for ligand designing using FDA-approved drugs and subsequent screen to identify molecules that exhibited high-affinity binding to AphB ligand-binding pocket. Among the identified compounds, ribavirin, an anti-viral drug, antagonized AphB functions. Ribavirin perturbed Vibrio cholerae pathogenesis in animal models. The inhibitory effects of the drug was limited to the bacteria expressing wild type AphB, but not its constitutively active mutant (AphBN100E), which represents the ligand-bound state, suggesting that ribavirin binds to the active site of AphB to exert its inhibitory role and there exists no AphB-independent mechanism of its action. Similarly, ribavirin suppressed the functions of Salmonella Typhi LTTR Hrg, indicating its broad spectrum efficacy. Moreover, ribavirin did not affect the bacterial viability in culture. This study cites an example of drug repurposing for anti-infective therapy.

SUBMITTER: Mandal RS 

PROVIDER: S-EPMC5171790 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Ribavirin suppresses bacterial virulence by targeting LysR-type transcriptional regulators.

Mandal Rahul Shubhra RS   Ta Atri A   Sinha Ritam R   Theeya Nagaraja N   Ghosh Anirban A   Tasneem Mohsina M   Bhunia Anirban A   Koley Hemanta H   Koley Hemanta H   Das Santasabuj S  

Scientific reports 20161219


Targeting bacterial virulence mechanisms without compromising bacterial growth is a promising strategy to prevent drug resistance. LysR-type transcriptional regulators (LTTRs) possess structural conservation across bacterial species and regulate virulence in numerous pathogens, making them attractive targets for antimicrobial agents. We targeted AphB, a Vibrio cholerae LTTR, which regulates the expression of genes encoding cholera toxin and toxin-co-regulated pilus for inhibitor designing. Since  ...[more]

Similar Datasets

| S-EPMC3004787 | biostudies-literature
| S-EPMC3180648 | biostudies-literature
| S-EPMC2897675 | biostudies-literature
| S-EPMC149827 | biostudies-literature
| S-EPMC6040199 | biostudies-literature
| S-EPMC5963692 | biostudies-literature
| S-EPMC2841617 | biostudies-literature
| S-EPMC5964159 | biostudies-literature
| S-EPMC8543017 | biostudies-literature
| S-EPMC6768210 | biostudies-literature